Skip to content

Efficacy of Yoga and Ayurveda in patients with metabolic syndrome on psychiatric medication

Efficacy of Integrated Yoga and Ayurveda based Lifestyle Intervention (IYALI) in patients with metabolic syndrome on antipsychotic medication: A Prospective pre-post Observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/12/038515
Enrollment
30
Registered
2021-12-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F312- Bipolar disorder, current episodemanic severe with psychotic features Health Condition 2: F333- Major depressive disorder, recurrent, severe with psychotic symptoms Health Condition 3: F302- Manic episode, severe with psychotic symptoms Health Condition 4: E889- Metabolic disorder, unspecified Health Condition 5: F200- Paranoid schizophrenia

Interventions

None listed

Sponsors

Dept of Integrative Medicine NIMHANS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with metabolic syndrome on antipsychotic medication with BMI > 24.9 and waist circumference >=90(male) >=80(female) 2.Patients on stable dose of antipsychotic medication for past 8 weeks. 3.Patients with metabolic syndrome before starting medications. 4.Patients willing to give an informed consent

Exclusion criteria

Exclusion criteria: 1.Patients with persistent and uncontrolled thyroid dysfunctions. 2.Patients on medications for metabolic syndrome from alternative medical systems. 3.Patients contra indicated for doing Kapalabhati like hypertension, seizure disorder, low back ache, glaucoma, recent abdominal surgery, hernia etc.

Design outcomes

Primary

MeasureTime frame
Changes in anthropometry, BMI BMR and body fat percentageTimepoint: At baseline, before and after 45 days of IYALI.

Secondary

MeasureTime frame
Changes in FBS and Lipid profileTimepoint: At baseline, before and after 45 days of IYALI.

Countries

India

Contacts

Public ContactDr SANTHOSH C

National Institute of Mental health and Neurosciences

ayurkishore@gmail.com9845829174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026